Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900588193> ?p ?o ?g. }
- W2900588193 endingPage "35961" @default.
- W2900588193 startingPage "35941" @default.
- W2900588193 abstract "// Françoise Boudouresque 1 , Carole Siret 1, 2 , Aurélie Dobric 1, 3 , Françoise Silvy 1, 3 , Philippe Soubeyran 3 , Juan Iovanna 3 , Dominique Lombardo 1 and Yolande Berthois 1, 3 1 Aix-Marseille Univ, INSERM UMR 911, CRO2, Marseille, France 2 Aix-Marseille Univ, CNRS, INSERM, CIML Marseille, France 3 Present address: Aix-Marseille University, INSERM, CNRS, Institut Paoli-Calmettes, CRCM, Pancreatic Cancer Team, Marseille, France Correspondence to: Yolande Berthois, email: yolande.berthois@univ-amu.fr Keywords: pancreatic cancer; micro-RNA-200; MCPiP1; dicer1 Received: April 04, 2018 Accepted: October 25, 2018 Published: November 13, 2018 ABSTRACT The microRNA-200 (miR-200) family is frequently down-regulated in tumors, including pancreatic adenocarcinomas (PDACs). In this study we have examined the mechanisms involved in the loss of miR-200s in tumoral pancreatic cells. Whereas miR-200 gene promoters appear methylated in mature miR-200 deficient cell lines, miR-200 precursors are detected in nuclear but not cytoplasmic compartment of these cells, indicating that promoter hypermethylation is not sufficient to explain the deficit of mature miR-200s. The ribonuclease Monocyte Chemotactic Protein-induced Protein-1 (MCPiP1) may counteract Dicer1 in miRNA maturation process. MCPiP1/Dicer1 mRNA and protein ratios appear higher in miR-200 deficient compared to miR-200 proficient cells, suggesting that MCPiP1 may compete with Dicer1 in mature miR-200 deficient cells. Inhibition of MCPiP1 allows the detection of miR-200 precursors in cytoplasm of miR-200 deficient cells, confirming its involvement in the loss of miR-200s. Also, reversion of MCPiP1/Dicer1 ratio by over-expression of Dicer1 in miR-200 deficient cells leads to the recovery of mature miR-200s. Finally, whereas human malignant pancreatic tissues (PDACs) express lower miR-200 levels than non malignant tissues (non-MPDs), MCPiP1/Dicer1 ratio appears higher in PDACs, when compared to non-MPDs, supporting the hypothesis that MCPiP1/Dicer1 ratio is determinant in regulating miR-200 maturation process in a subset of tumoral pancreatic cells." @default.
- W2900588193 created "2018-11-29" @default.
- W2900588193 creator A5027203519 @default.
- W2900588193 creator A5046347197 @default.
- W2900588193 creator A5062024088 @default.
- W2900588193 creator A5066948009 @default.
- W2900588193 creator A5074609153 @default.
- W2900588193 creator A5080041218 @default.
- W2900588193 creator A5085593167 @default.
- W2900588193 creator A5091873648 @default.
- W2900588193 date "2018-11-13" @default.
- W2900588193 modified "2023-09-30" @default.
- W2900588193 title "Ribonuclease MCPiP1 contributes to the loss of micro-RNA-200 family members in pancreatic cancer cells" @default.
- W2900588193 cites W1536340771 @default.
- W2900588193 cites W1964287896 @default.
- W2900588193 cites W1969208117 @default.
- W2900588193 cites W1976324983 @default.
- W2900588193 cites W1980269624 @default.
- W2900588193 cites W1991563094 @default.
- W2900588193 cites W1996350041 @default.
- W2900588193 cites W2006767098 @default.
- W2900588193 cites W2011382807 @default.
- W2900588193 cites W2014064723 @default.
- W2900588193 cites W2017905687 @default.
- W2900588193 cites W2030003939 @default.
- W2900588193 cites W2032220606 @default.
- W2900588193 cites W2038085099 @default.
- W2900588193 cites W2038553122 @default.
- W2900588193 cites W2042912493 @default.
- W2900588193 cites W2043473071 @default.
- W2900588193 cites W2045402423 @default.
- W2900588193 cites W2048910343 @default.
- W2900588193 cites W2054109341 @default.
- W2900588193 cites W2059357290 @default.
- W2900588193 cites W2063375027 @default.
- W2900588193 cites W2063880647 @default.
- W2900588193 cites W2064266708 @default.
- W2900588193 cites W2075207798 @default.
- W2900588193 cites W2079248832 @default.
- W2900588193 cites W2082213106 @default.
- W2900588193 cites W2084343070 @default.
- W2900588193 cites W2088847779 @default.
- W2900588193 cites W2092200047 @default.
- W2900588193 cites W2097681338 @default.
- W2900588193 cites W2099517697 @default.
- W2900588193 cites W2100751052 @default.
- W2900588193 cites W2101136328 @default.
- W2900588193 cites W2104229806 @default.
- W2900588193 cites W2105053318 @default.
- W2900588193 cites W2107312379 @default.
- W2900588193 cites W2107976675 @default.
- W2900588193 cites W2110773510 @default.
- W2900588193 cites W2112192177 @default.
- W2900588193 cites W2125120607 @default.
- W2900588193 cites W2130979840 @default.
- W2900588193 cites W2135412450 @default.
- W2900588193 cites W2142421871 @default.
- W2900588193 cites W2142636026 @default.
- W2900588193 cites W2144850478 @default.
- W2900588193 cites W2147545983 @default.
- W2900588193 cites W2149291473 @default.
- W2900588193 cites W2155131748 @default.
- W2900588193 cites W2157923000 @default.
- W2900588193 cites W2158299354 @default.
- W2900588193 cites W2162038712 @default.
- W2900588193 cites W2165804743 @default.
- W2900588193 cites W2206242981 @default.
- W2900588193 cites W2401593087 @default.
- W2900588193 cites W2443178263 @default.
- W2900588193 cites W2443555011 @default.
- W2900588193 cites W2514305496 @default.
- W2900588193 cites W2604918044 @default.
- W2900588193 cites W4251765607 @default.
- W2900588193 doi "https://doi.org/10.18632/oncotarget.26310" @default.
- W2900588193 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6267598" @default.
- W2900588193 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30542509" @default.
- W2900588193 hasPublicationYear "2018" @default.
- W2900588193 type Work @default.
- W2900588193 sameAs 2900588193 @default.
- W2900588193 citedByCount "10" @default.
- W2900588193 countsByYear W29005881932019 @default.
- W2900588193 countsByYear W29005881932020 @default.
- W2900588193 countsByYear W29005881932021 @default.
- W2900588193 countsByYear W29005881932022 @default.
- W2900588193 crossrefType "journal-article" @default.
- W2900588193 hasAuthorship W2900588193A5027203519 @default.
- W2900588193 hasAuthorship W2900588193A5046347197 @default.
- W2900588193 hasAuthorship W2900588193A5062024088 @default.
- W2900588193 hasAuthorship W2900588193A5066948009 @default.
- W2900588193 hasAuthorship W2900588193A5074609153 @default.
- W2900588193 hasAuthorship W2900588193A5080041218 @default.
- W2900588193 hasAuthorship W2900588193A5085593167 @default.
- W2900588193 hasAuthorship W2900588193A5091873648 @default.
- W2900588193 hasBestOaLocation W29005881931 @default.
- W2900588193 hasConcept C104317684 @default.
- W2900588193 hasConcept C121608353 @default.
- W2900588193 hasConcept C126322002 @default.
- W2900588193 hasConcept C145059251 @default.